See also this year's filing and all EDGAR filings for this company.
PDF Report 0001260990_2018_Oncternal_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001260990, Oncternal Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 46,077,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 108,000 |
| 2 | PropertyPlantAndEquipmentNet | 51,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 7,975,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,084,759 |
| 9 | ResearchAndDevelopmentExpense | 22,859,164 |
| 10 | remainder_Expenses | -1,638,323 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 165,533 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 46,236,000 |
| 1 | Liabilities | 7,975,000 |
| 2 | Expenses | 30,305,600 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 38,261,000 |
| 5 | NetIncome | -30,140,067 |
| 6 | ComprehensiveNetIncome | -30,140,067 |
| 7 | BaseVar | 42,341,066 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.97 |
| 9 | EconomicCapitalRatio | 3.00 |
Edgar->Model Mapping
Feature Distribution
Change over Time
